This could be true specifically for breast cancer given the expression of TOP2B in >90% of breast cancer while TOP2A expression is limited in breast tumors as well as since TOP2B rather than TOP2A has been shown to be a better predictor for breast cancer survival in patients (Sandri et al., 1996; Bonnefoi, 2011). This evidence concerns the gene TOP2B and breast cancer.